SmartLabs to Convert CambridgeSide Mall Space to Research Center

Posted by ISPE Boston
On March 9, 2023

Boston-based SmartLabs, developer of “Managed Research Centers,” is launching a new research, development, office and related production center at the CambridgeSide mall. Set to open in late 2024. the complex will be SmartLabs’ most advanced facility to date, according to its website. The new facility will join SmartLabs’ four existing Managed Research Centers in Cambridge […]

Chapter Member Anniversaries: March 2023

Posted by ISPE Boston
On March 6, 2023

Please congratulate the following members celebrating milestone anniversaries in March 2023. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Saboo Aghababayan, National Resilience Danielle Bottari, Pfizer Charles Cooney, MIT Chemical Engineering Robert Davis, Process Control Solutions Michael Diker, Bristol-Myers Squibb Brian Duffy, Integrated Project Services Eric Felz, […]

Welcome New Members February 2023!

Posted by ISPE Boston
On March 6, 2023

We would like to introduce the Members who joined ISPE in February 2023, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Aera Therapeutics Launches with $193M from Investors

Posted by ISPE Boston
On March 2, 2023

Boston’s Aera Therapeutics announced its launch last month with $193 million in combined Series A and B financings and a vision to harness its proprietary delivery platform to “unlock the potential of genetic medicines across a wide range of modalities and therapeutic areas.” Aera’s delivery platform is designed to address the limitations of today’s delivery […]

Moderna’s mRNA Platform to Team with Life Edit’s Gene Editing Technologies

Posted by ISPE Boston
On March 2, 2023

Moderna and Life Edit Therapeutics, an ElevateBio company based in Durham, NC, are forming a strategic research and development collaboration to discover and develop in vivo mRNA gene editing therapies. The partnership will combine Life Edit’s suite of proprietary gene editing technologies, including base editing, with Moderna’s mRNA platform to advance in vivo gene editing therapies against a select […]

Emerging Leaders Professional Development Series off to a Great Start!

Posted by Irtiza Akhtar
On February 28, 2023

This past Wednesday, February 22, 2023, Emerging Leaders hosted their inaugural Professional Development Series: Single-Use Technology Lifecycle Management. Forty people came to this sold-out event at the Craft Food Hall in Waltham to enjoy some yummy snacks and networking before settling in to enjoy the presentation by Mark Maselli, the Associate Director of Engineering and […]

Students Fill the Classroom at the Annual Career Workshop

Posted by Ryan Mazur
On February 23, 2023

This past Saturday, February 18th, the Student Development Committee hosted the Student Career Development Workshop in-person for the first time since the start of the pandemic. The event featured resume, cover letter, and interview advice; an inaugural Talent Acquisition Panel; networking lunch with resume reviews; information sessions from MassBioEd and Massachusetts Life Sciences Center (MLSC) […]

Women in Pharma Candle Making was LIT!

Posted by Brooke Cote
On February 17, 2023

The Women in Pharma candle making class last night was lit (haha)! We had a sold out event filled with fun, laughs, and networking. We got to learn the science behind a candle! It was so interesting to learn that other candles may have harmful chemicals and metals in them. Kitchen Sink Candle Making Company, […]

Call for ISPE Board of Directors Nominations!

Posted by ISPE Boston
On February 17, 2023

Do you know a member of ISPE Boston who would be well-suited to serve on the ISPE Boston Area Chapter Board of Directors? In an effort to represent a global view of our industry and to ensure organizational success, it is important we have an appropriately diverse Board of Directors. Diversity is represented in many […]

Frequency to Restructure, Focus on MS Therapy

Posted by ISPE Boston
On February 16, 2023

Lexington’s Frequency Therapeutics has announced that the Phase 2b study of its hearing loss therapy FX-322 has failed to meet its primary endpoint. As a result, the company will discontinue the FX-322 development program along with a related program. Frequency’s efforts will now focus on continuing to develop novel therapeutics to induce remyelination for individuals […]

Page 25 of 118«‹23 242526 27 ›»